Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Røsjø

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Clinical Science (London, England : 1979)|April 9, 2009
New statistical methods for the evaluation of cardiovascular risk markers: what the clinician should knowHelge Røsjø, Torbjørn Omland
Expert Review of Cardiovascular Therapy|December 13, 2025
Secretoneurin as a novel cardiovascular biomarker and potential therapeutic strategyAnett H Ottesen, Helge Røsjø, Torbjørn Omland
The American Journal of Cardiology|May 3, 2011
Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomyHelge Røsjø, Johanna Andreassen, Thor Edvardsen, et al.
Current Heart Failure Reports|October 5, 2017
Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart FailureAnett H Ottesen, Geir Christensen, Torbjørn Omland, et al.
Critical Reviews in Clinical Laboratory Sciences|November 21, 2018
Novel biomarkers of cardiovascular disease: Applications in clinical practiceMagnus Nakrem Lyngbakken, Peder Langeland Myhre, Helge Røsjø, et al.
Clinical Biochemistry|June 5, 2023
Prognostic value of secretoneurin in chronic heart failure. Data from the GISSI-Heart Failure trialHelge Røsjø, Jennifer Meessen, Anett Hellebø Ottesen, et al.
The American Journal of Cardiology|October 27, 2016
Relation of Erectile Dysfunction to Subclinical Myocardial InjuryTorbjørn Omland, Anna Randby, Harald Hrubos-Strøm, et al.
Journal of the American Heart Association|April 19, 2024
Systolic Blood Pressure, Diastolic Blood Pressure and Pulse Pressure and the Risk of Subclinical Myocardial Injury: The HUNT StudyJuliet Young, Magnus Nakrem Lyngbakken, Kristian Hveem, et al.
Journal of the American Heart Association|January 10, 2022
Tobacco Consumption and High-Sensitivity Cardiac Troponin I in the General Population: The HUNT StudyJulia Brox Skranes, Magnus Nakrem Lyngbakken, Kristian Hveem, et al.
Journal of Internal Medicine|October 20, 2021
Lifetime obesity trends are associated with subclinical myocardial injury: The Trøndelag health studyMagnus Nakrem Lyngbakken, James A de Lemos, Kristian Hveem, et al.
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Clinical Science (London, England : 1979)|April 9, 2009
New statistical methods for the evaluation of cardiovascular risk markers: what the clinician should knowHelge Røsjø, Torbjørn Omland
Expert Review of Cardiovascular Therapy|December 13, 2025
Secretoneurin as a novel cardiovascular biomarker and potential therapeutic strategyAnett H Ottesen, Helge Røsjø, Torbjørn Omland
The American Journal of Cardiology|May 3, 2011
Prognostic usefulness of circulating high-sensitivity troponin T in aortic stenosis and relation to echocardiographic indexes of cardiac function and anatomyHelge Røsjø, Johanna Andreassen, Thor Edvardsen, et al.
Current Heart Failure Reports|October 5, 2017
Glycosylated Chromogranin A: Potential Role in the Pathogenesis of Heart FailureAnett H Ottesen, Geir Christensen, Torbjørn Omland, et al.
Critical Reviews in Clinical Laboratory Sciences|November 21, 2018
Novel biomarkers of cardiovascular disease: Applications in clinical practiceMagnus Nakrem Lyngbakken, Peder Langeland Myhre, Helge Røsjø, et al.
Clinical Biochemistry|June 5, 2023
Prognostic value of secretoneurin in chronic heart failure. Data from the GISSI-Heart Failure trialHelge Røsjø, Jennifer Meessen, Anett Hellebø Ottesen, et al.
The American Journal of Cardiology|October 27, 2016
Relation of Erectile Dysfunction to Subclinical Myocardial InjuryTorbjørn Omland, Anna Randby, Harald Hrubos-Strøm, et al.
Journal of the American Heart Association|April 19, 2024
Systolic Blood Pressure, Diastolic Blood Pressure and Pulse Pressure and the Risk of Subclinical Myocardial Injury: The HUNT StudyJuliet Young, Magnus Nakrem Lyngbakken, Kristian Hveem, et al.
Journal of the American Heart Association|January 10, 2022
Tobacco Consumption and High-Sensitivity Cardiac Troponin I in the General Population: The HUNT StudyJulia Brox Skranes, Magnus Nakrem Lyngbakken, Kristian Hveem, et al.
Journal of Internal Medicine|October 20, 2021
Lifetime obesity trends are associated with subclinical myocardial injury: The Trøndelag health studyMagnus Nakrem Lyngbakken, James A de Lemos, Kristian Hveem, et al.
Pageof 15